Scholar Rock Holding (SRRK) Selling, General & Administrative (2017 - 2026)

Scholar Rock Holding (SRRK) Selling, General & Administrative (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 69,146.49 Bn 69,146.20 Bn - -10.08 Mn
2 Nanobiotix 1,942.19 Bn 1,942.13 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - 2.17 Mn
4 BeOne Medicines 475.42 Bn 470.63 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 123.32 Bn 116.08 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 69.80 Bn 61.04 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 63.28 Bn 63.28 Bn - 17.02 Mn
8 Argenx Se 56.67 Bn 51.48 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 38.15 Bn 38.15 Bn - 101.25 Mn
10 Scholar Rock Holding 6.29 Bn 6.29 Bn - 50.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 50.20 Mn
Dec 31, 2025 45.02 Mn
Sep 30, 2025 53.06 Mn
Jun 30, 2025 49.71 Mn
Mar 31, 2025 28.41 Mn
Dec 31, 2024 18.99 Mn
Sep 30, 2024 16.06 Mn
Jun 30, 2024 17.13 Mn
Mar 31, 2024 15.33 Mn
Dec 31, 2023 13.07 Mn
Sep 30, 2023 13.34 Mn
Jun 30, 2023 12.22 Mn
Mar 31, 2023 10.77 Mn
Dec 31, 2022 10.82 Mn
Sep 30, 2022 10.47 Mn
Jun 30, 2022 11.07 Mn
Mar 31, 2022 10.76 Mn
Dec 31, 2021 10.36 Mn
Sep 30, 2021 11.28 Mn
Jun 30, 2021 9.27 Mn